| Citation: |
TANG Enhong, CAI Wang. Effects of Pachymaran on Proliferation, Migration and Pro-apoptosis of Human Cervical Carcinoma HeLa Cells and Its Mechanism[J]. Cancer Research on Prevention and Treatment, 2019, 46(8): 707-713. DOI: 10.3971/j.issn.1000-8578.2019.18.1960
|
To investigate the effects of pachymaran on the proliferation, migration and pro-apoptosis of human cervical carcinoma HeLa cells and their related mechanisms.
MTT method was used to detect cell proliferation rate, and we selected the suitable low, medium and high concentrations of pachymaran for experiment. After treatment with low, medium and high concentrations of pachymaran, the morphological changes were observed by inverted phase contrast microscope; nuclear changes were observed by Hoechst 33342 staining; flat plate clone formation test was used to detect the ability of cell clone; cell scratch test was used to detect cell migration ability; flow cytometry was used to detect the apoptosis rate and cell cycle distribution. The expression of related proteins of apoptosis, migration and ERK pathway were detected by Western blot.
We selected 30, 40 and 50 mg/ml pachymaran were selected as low, medium and high concentrations in the experiments. After treated with medium and high concentrations of pachymaran, cells and cell nuclei had significant apoptosis morphological changes, but not at low concentration. Different concentrations of pachymaran could reduce the abilities of cell cloning and migration (P < 0.05), increase apoptotic rate (P < 0.05), decreased S phase cells and blocked in G2/M phase (P < 0.05); Cleaved Caspase 3, Cleaved Caspase 8, Cleaved Caspase 9, Bax expression were increased significantly compared with the control group; Bcl-2, MMP-9, VEGFA and p-ERK1/2 expression were decreased significantly (P < 0.05). ERK1/2 expression did not change significantly.
Pachymaran could significantly inhibit the proliferation and induce the apoptosis of HeLa cells. The pro-apoptotic mechanism may be related to the inhibition of phosphorylation of ERK signaling pathway by downregulating the expression of p-ERK1/2. In addition, pathymaran could reduce the migration of HeLa cells to a certain extent.
| [1] |
曹颖.茯苓多糖药理作用的研究[J].中国现代药物应用, 2013, 7(13): 217-218. doi: 10.3969/j.issn.1673-9523.2013.13.183
Cao Y. Study on pharmacological action of poria cocos polysaccharide[J]. Zhongguo Xian Dai Yao Wu Ying Yong, 2013, 7 (13): 217-218. doi: 10.3969/j.issn.1673-9523.2013.13.183
|
| [2] |
彭志清, 唱晓飞.茯苓多糖治疗宫颈癌的临床疗效[J].世界临床医学, 2016, 10(17): 127-128. http://d.old.wanfangdata.com.cn/Periodical/sjlcyx201617105
Peng ZQ, Chang XF. Clinical efficacy of poria cocos polysaccharide in the treatment of cervical cancer[J]. Shi Jie Lin Chuang Yi Xue, 2016, 10 (17): 127-128. http://d.old.wanfangdata.com.cn/Periodical/sjlcyx201617105
|
| [3] |
侯玮婷, 罗佳波.复方茯苓多糖口服液抗肿瘤作用和免疫调节功能的初步研究[J].中药药理与临床, 2017, 33(2): 78-81. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zyylylc201702021
Hou WT, Luo JB. The study of the compound poria polysaccharide oral liquid on the antitumor activity and immune regulation function[J]. Zhong Yao Yao Li Yu Lin Chuang, 2017, 33(2): 78-81. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zyylylc201702021
|
| [4] |
郭晨旭, 钱军.茯苓对胃癌细胞株SGC-7901的侧群细胞增殖的影响[J].中国临床药理学与治疗学, 2014, 19(11): 1222-1226. http://d.old.wanfangdata.com.cn/Periodical/zglcylxyzlx201411005
Guo CX, Qian J. Effects of poria cocos on the proliferation of side group cells of gastric cancer cell line SGC-7901[J]. Zhongguo Lin Chuang Yao Li Xue Yu Zhi Liao Xue, 2014, 19(11): 1222-1226. http://d.old.wanfangdata.com.cn/Periodical/zglcylxyzlx201411005
|
| [5] |
许云霞, 刘晓健, 屈飞.中药多糖与过继免疫联合治疗卵巢癌[J].中国实验方剂学杂志, 2011, 17(21): 231-234. doi: 10.3969/j.issn.1005-9903.2011.21.064
Xu YX, Liu XJ, Qu F. Treatment of ovarian cancer with chinese herbal polysaccharide combined with adoptive immunization[J]. Zhongguo Shi Yan Fang Ji Xue Za Zhi, 2011, 17(21): 231-234. doi: 10.3969/j.issn.1005-9903.2011.21.064
|
| [6] |
张密霞, 李怡文, 张德生, 等.茯苓多糖对Lewis肺癌小鼠自发肺转移的抑制作用及其机制研究[J].现代药物与临床, 2013, 28(6): 842-846. http://d.old.wanfangdata.com.cn/Periodical/gwyy-zwyfc201306007
Zhang MX, Li YW, Zhang DS, et al. Inhibition of pachymaran on spontaneous lung metastasis in Lewis lung cancer of mice and its mechanism[J]. Xian Dai Yao Wu Yu Lin Chuang, 2013, 28 (6): 842-846. http://d.old.wanfangdata.com.cn/Periodical/gwyy-zwyfc201306007
|
| [7] |
Li X, Zheng R, Li X, et al. Trends of incidence rate and age at diagnosis for cervical cancer in China, from 2000 to 2014[J]. Chin J Cancer Res, 2017, 29(6): 477-486. doi: 10.21147/j.issn.1000-9604.2017.06.02
|
| [8] |
Symonds RP, Davidson SE, Chan S, et al. SCOTCERV: a phase Ⅱ trial of docetaxel and gemcitabine as second line chemotherapy in cervical cancer[J]. Gynecol Oncol, 2011, 123(1): 105-109. doi: 10.1016/j.ygyno.2011.06.001
|
| [9] |
Bartkova J, Lukas J, Müller H, et al. Cyclin D1 protein expression and function in human breast cancer[J]. Int J Cancer, 2010, 57(3): 353-361. http://cn.bing.com/academic/profile?id=0db208c18d09f42b6595e8c72810bbe5&encoded=0&v=paper_preview&mkt=zh-cn
|
| [10] |
Goilav B, Satlin LM, Wilson PD. Pathways of apoptosis in human autosomal recessive and autosomal dominant polycystic kidney diseases[J]. Pediatr NePhrol, 2008, 23(9): 1473-1482. doi: 10.1007/s00467-008-0851-9
|
| [11] |
Farin A, Suzuki SO, Weiker M, et al. TransPlanted glioma cells migrate and Proliferate on host brain vasculature: a dynamic analysis[J]. Glia, 2006, 53(8): 799-808. doi: 10.1002/glia.20334
|
| [12] |
陈晓静, 王薇, 周琛斐, 等.肿瘤相关巨噬细胞促进宫颈癌侵袭转移的机制研究[J].肿瘤防治研究, 2019, 46(3): 212-217. doi: 10.3971/j.issn.1000-8578.2019.18.0769
Chen XJ, Wang W, Zhou CF, et al. Tumor associated macrophages promote invasion and metastasis of cervical cancer[J]. Zhong Liu Fang Zhi Yan Jiu, 2019, 46(3): 212-217. doi: 10.3971/j.issn.1000-8578.2019.18.0769
|
| [13] |
Sui X, Kong N, Ye L, et al. P38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents[J]. Cancer Lett, 2014, 344(2): 174-179. doi: 10.1016/j.canlet.2013.11.019
|
| [1] | ZHU Xiaoli, XU Lu. Research Progress of Markers Related to Early Diagnosis of Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2022, 49(9): 875-879. DOI: 10.3971/j.issn.1000-8578.2022.21.1483 |
| [2] | LI Huihui, SUN Xiaodan, ZHAO Peiyan, ZHANG Shuang, CHENG Ying. Research Status of Biomarkers in Early Screening and Early Diagnosis of Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2022, 49(4): 364-369. DOI: 10.3971/j.issn.1000-8578.2022.21.0964 |
| [3] | XIAO Zhihao, XIAO Yao, LU Xiaodan, LI Wendan. Circular RNA: A Potential Biomarker for Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2019, 46(7): 654-657. DOI: 10.3971/j.issn.1000-8578.2019.18.1589 |
| [4] | ZOU Yupeng, LI Li. Research and Application of New Serum Tumor Markers in Ovarian Cancer[J]. Cancer Research on Prevention and Treatment, 2017, 44(9): 631-635. DOI: 10.3971/j.issn.1000-8578.2017.17.0078 |
| [5] | ZHANG Li, JIAO Kai. Specific Biomarkers and Related Gene of Medullary Thyroid Carcinoma[J]. Cancer Research on Prevention and Treatment, 2014, 41(12): 1357-1360. DOI: 10.3971/j.issn.1000-8578.2014.12.023 |
| [6] | PEI Aoqiu, LUO Mao, HE Xiaobin. Recent Progress of microRNA as Colorectal Cancer Clinical Biomarker[J]. Cancer Research on Prevention and Treatment, 2014, 41(07): 839-843. DOI: 10.3971/j.issn.1000-8578.2014.07.033 |
| [7] | CHEN Liru, XU Jianjun, WEI Yiping. Progress in Mass Spectrometry and Its Application in Lung Cancer Biomarker Research[J]. Cancer Research on Prevention and Treatment, 2014, 41(07): 820-824. DOI: 10.3971/j.issn.1000-8578.2014.07.029 |
| [8] | Li Guangjian, Huang Yunchao, He Yuefeng, Chen Jinbao, Yang Kaiyun, Zhao Guangqiang, Lei Yujie, Chen Ying. Study of miRNA Signatures as Biomarkers for Early Stage Nonsmoking Female Lung Cancer of Xuanwei County of Yunnan Province[J]. Cancer Research on Prevention and Treatment, 2012, 39(07): 802-806. DOI: 10.3971/j.issn.1000-8578.2012.07.010 |
| [9] | HE Xiao-jiang, YU Hao, WU Hua, HUANG Jin-xiong, YU Dan, SU Xin-hui. Value of Serum Tumor Markers in Predicting Bone Metastases of Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2006, 33(08): 583-584. DOI: 10.3971/j.issn.1000-8578.1825 |
| [10] | LIU Bin, CUI Jian-feng, LIU Xin-fu, CHEN Wen, CHEN Feng, LV Ning, PAN Qin-jing, WEI Wen-qiang, QIAO You-lin. Serum Markers as Predictors of Esophageal Squamous Dysplasia and Early Cancer[J]. Cancer Research on Prevention and Treatment, 2006, 33(08): 551-554. DOI: 10.3971/j.issn.1000-8578.1848 |
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: